SPDR S&P Biotech ETF (XBI) - Stock Analysis
Last updated: Dec 5, 2025
Financial ServicesClosed
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
SPDR S&P Biotech ETF shows bullish technical trends (+8% over 21 days, maintains price above 21-day SMA) amid improving sector fundamentals including increased funding, M&A activity, and regulatory tailwinds, positioning it as a hot idea for short-term biotech exposure.
Loading chart data...
Idea window: 12/5/2025 – 12/12/2025Sector: Financial Services
AI Analyst Overview
Last Price
$121.83
Market Cap
$6.31B
1D Return
-0.64%
YTD Return
-0.08%
Loading chart data...
Valuation Metrics
P/E
—
P/B
—
P/S
—
EV/EBITDA
—
Div Yield
—
Description
The fund tracks the S&P Biotechnology Select Industry Index through a sampling strategy and generally holds substantially all, but at least 80%, of its assets in the index’s constituent securities. The index represents the biotechnology portion of the S&P Total Market Index.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Dec 5 | Dec 12 | XBI | SPDR S&P Biotech ETF | SPDR S&P Biotech ETF shows bullish technical trends (+8% over 21 days, maintains price above 21-day SMA) amid improving sector fundamentals including increased funding, M&A activity, and regulatory tailwinds, positioning it as a hot idea for short-term biotech exposure. | Closed | -0.2% |